Substantial advances in the management of ST-segment elevation myocardial infarction (STEMI) have occurred in the last decade. A disturbing note, however, is the recognition that the rate of cardiovascular mortality after discharge is still unacceptably high. With many therapeutic options available, the clinician is challenged to identify the safest and most effective treatment for long-term survival of each individual patient. Steps in this process may include simple prognostic markers that reflect pathophysiologic mechanisms to be identified. Empiric testing and further confirmation of new or old score markers remain essential.
STEMI: Prognosis
Cenko, E.
;Ricci, B.;Bugiardini, R.
2018
Abstract
Substantial advances in the management of ST-segment elevation myocardial infarction (STEMI) have occurred in the last decade. A disturbing note, however, is the recognition that the rate of cardiovascular mortality after discharge is still unacceptably high. With many therapeutic options available, the clinician is challenged to identify the safest and most effective treatment for long-term survival of each individual patient. Steps in this process may include simple prognostic markers that reflect pathophysiologic mechanisms to be identified. Empiric testing and further confirmation of new or old score markers remain essential.File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
